2014-08-13T15:14:58-05:00 2013-12-31 221430039 SOBEL AND CO LLC CPA'S 293 EISENHOWER PARKWAY LIVINGSTON NJ 070391711 990 2013-01-01 208735688 SOLVING KIDS CANCER INC SOLV 2125886624 1 EAST 53RD STREET 5TH FLOOR NEW YORK NY 10022 SCOTT KENNEDY EXECUTIVE DIRECTOR 2125886624 2014-08-13 1 BRIDGET HARTNETT P01429163 9739949494 2014-08-13 2013 2015-11-30 17:44:51Z SCOTT KENNEDY 1 EAST 53RD STREET 5TH FLOOR NEW YORK NY 10022 804412 0 X WWW.SOLVINGKIDSCANCER.ORG X 2006 NY SOLVING KIDS' CANCER FINDS, FUNDS, AND MANAGES CLINICAL RESEARCH TRIALS TO FACILITATE THE DEVELOPMENT OF MORE EFFECTIVE AND LESS TOXIC TREATMENTS FOR THE DEADLIEST CHILDHOOD CANCERS. 100 % OF PUBLIC DONATIONS ARE USED FOR PROGRAM AND RESEARCH SUPPORT GRANTS. 9 8 4 8 0 0 566915 743573 0 0 11123 7027 171787 -118356 749825 632244 522084 449622 0 0 457206 443499 0 0 166397 127799 223178 1107089 1116299 -357264 -484055 3536188 3041656 15190 4713 3520998 3036943 X SOLVING KIDS' CANCER FINDS, FUNDS, AND MANAGES CLINICAL RESEARCH TRIALS TO FACILITATE THE DEVELOPMENT OF MORE EFFECTIVE AND LESS TOXIC TREATMENTS FOR THE DEADLIEST CHILDHOOD CANCERS. 100 % OF PUBLIC DONATIONS ARE USED FOR PROGRAM AND RESEARCH SUPPORT GRANTS. 0 0 794094 449622 SOLVING KIDS CANCER IDENTIFIES FUNDS AND MANAGES A DIVERSE PORTFOLIO OF CLINICAL RESEARCH PROGRAMS TO TREAT CHILDREN ALIVE TODAY AND TO IDENTIFY NEW CURATIVE PATHS FOR THE FUTURE. IN 6 YEARS, SKC HAS AWARDED OVER $4 MILLION IN GRANTS IN 23 RESEARCH PROJECTS THAT HAVE ALREADY LEAD TO 14 NEW TREATMENTS. RESEARCH PROJECTS FUNDED IN 2013 INCLUDE: IDENTIFICATION OF NEW NEUROBLASTOMA TARGET ANTIGENS FOR GENERATING NEW IMMUNOTHERAPIES USING T-CELLS AND NK CELLS; PHASE I CLINICAL TRIAL OF GD2 T-CELL CARS IN MULTIPLE INFUSIONS FOR NEUROBLASTOMA; DEVELOPMENT OF THERAPEUTIC ALK ANTIBODY FOR NEUROBLASTOMA; PHASE I CLINICAL TRIAL OF MK-1775 WEE 1 INHIBITOR + IRINOTECAN TARGETING MICRORNA-497 FOR NEUROBLASTOMA AND MEDULLOBLASTOMA; AND A PHASE I CLINICAL TRIAL OF 3RD GENERATION GD2 T-CELL CARS WITH A SAFETY SWITCH FOR NEUROBLASTOMA. 794094 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 15 0 1 4 1 0 0 0 0 0 1 1 0 0 0 0 X 9 8 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 NY X THE ORGANIZATION 2125886624 1 EAST 53RD STREET 5TH FLOOR NEW YORK NY 10022 JOHN LONDON CHAIRMAN, CO-FOUNDER 2.00 X X 0 0 0 SCOTT KENNEDY EXECUTIVE DIRECTOR, CO-FOUNDER 40.00 X X 200000 0 25582 KHALIL BARRAGE DIRECTOR 2.00 X 0 0 0 DAVID BLAUSTEIN CHIEF SCIENTIFIC OFFICER 2.00 X X 0 0 0 JOHN CODLING DIRECTOR 2.00 X 0 0 0 CATHERINE LONDON DIRECTOR 2.00 X 0 0 0 WAYNE ROBINSON TREASURER 2.00 X X 0 0 0 ARI SPAR DIRECTOR 2.00 X 0 0 0 CHANNING STAVE SECRETARY 2.00 X X 0 0 0 200000 0 25582 1 0 1 0 0 434389 309184 743573 7027 7027 53812 434389 172168 -118356 -118356 632244 0 0 -111329 423222 423222 26400 26400 225582 180466 11279 33837 184299 69523 67991 46785 9570 2399 4410 2761 24048 13278 5699 5071 13175 13175 107334 47445 4670 55219 8752 8752 4231 4231 46398 27588 9509 9301 4488 3183 324 981 154 154 12714 12714 865 865 MISCELLANEOUS 10935 2517 8418 DATABASE EXPENSE 5465 5465 PRINTING AND SHIPPING 5354 2556 2798 MEALS AND ENTERTAINMENT 2318 590 502 1226 995 995 1116299 794094 155808 166397 3490693 259242 2705119 3260 0 26391 56954 110026 93270 15844 16756 3585 3536188 3041656 15190 4713 15190 4713 X 3520998 2994943 42000 3520998 3036943 3536188 3041656 -484055 0 X X 0 1 X 1 0 X 563528 706262 1047437 738702 309184 3365113 563528 706262 1047437 738702 309184 3365113 577080 2788033 50959 25234 15625 11123 7027 109968 3475081 0.80230 0.62200 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3065 3065 0 106961 90205 16756 16756 X 632244 0 632244 0 632244 1116299 0 1116299 0 1116299 PART X, LINE 2: THE ORGANIZATION FOLLOWS STANDARDS THAT PROVIDE CLARIFICATION ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES RECOGNIZED IN THE ORGANIZATION'S FINANCIAL STATEMENTS. THE GUIDANCE PRESCRIBES A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR THE RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, AND ALSO PROVIDES GUIDANCE ON DERECOGNITION, CLASSIFICATION, INTEREST AND PENALTIES, DISCLOSURE AND TRANSITION. THE ORGANIZATION'S POLICY IS TO RECOGNIZE INTEREST AND PENALTIES ON UNRECOGNIZED TAX BENEFITS IN INCOME TAX EXPENSE. NO INTEREST AND PENALTIES WERE RECORDED DURING 2013 AND 2012. THE TAX YEARS SUBJECT TO AUDIT BY FEDERAL AND STATE JURISDICTIONS ARE THE YEARS ENDED DECEMBER 31, 2010 AND FORWARD. AT DECEMBER 31, 2013 AND 2012, THERE ARE NO SIGNIFICANT INCOME TAX UNCERTAINTIES. X X X X 0 EVENT ASSOCIATES 162 WEST 56TH STREET 4TH FLOOR NEW YORK NY 10019 HELP WITH ORGANIZATION OF SPRING CELEBRATION 0 482389 63261 419128 482389 63261 419128 SPRING CELEBRATION 482389 434389 48000 0 0 57462 114356 JUNIOR BOARD EVENT 5812 0 5812 350 488201 434389 53812 57462 114706 172168 -118356 SCHEDULE G, PART I, LINE 2B, COLUMN (V) PAYMENTS WERE MADE TO FUNDRAISER TO HELP ORGANIZE THE SPRING CELEBRATION 1 NATIONAL CANCER INSTITUTE 10 CENTER DR MSC 1104 BETHESDA MD 20892 501(C)(3) 50000 CASH CANCER RESEARCH CHILDREN'S HOSPITAL OF PHILADELPHIA 3615 CIVIC CENTER BOULEVARD PHILADELPHIA PA 19104 231352166 501(C)(3) 39363 CASH CANCER RESEARCH BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA HOUSTON TX 77030 741613878 501(C)(3) 83000 CASH CANCER RESEARCH JOHNS HOPKINS UNIVERSITY 242 GARLAND HALL BALTIMORE MD 21218 520595110 501(C)(3) 189359 CASH CANCER RESEARCH CHILDREN'S HOSPITAL OF PHILADELPHIA 3615 CIVIC CENTER BOULEVARD PHILADELPHIA PA 19104 231352166 501(C)(3) 50000 CASH CANCER RESEARCH CHILDREN'S HOSPITAL OF PHILADELPHIA 3615 CIVIC CENTER BOULEVARD PHILADELPHIA PA 19104 231352166 501(C)(3) 11500 CASH CANCER RESEARCH SCIENTIFIC ADVISORY CONSULTING 1 26400 CASH PART I, LINE 2: THE ORGANIZATION EXPENDS FUNDS IN CONNECTION WITH GRANT COMMITMENTS AS EACH GRANTEE ACCOMPLISHES SPECIFIC MILESTONES SET FORTH IN EACH GRANT AGREEMENT. EACH GRANTEE IS REQUIRED TO SUBMIT PROGRESS REPORTS ON A PERIODIC BASIS AS MILESTONES ARE ACHIEVED PURSUANT TO THE GRANT AGREEMENTS. X X X 0 0 0 0 0 0 0 0 0 SCOTT KENNEDY EXECUTIVE DIRECTOR, CO-FOUNDER 200000 0 0 0 0 0 0 0 25582 0 225582 0 0 0 PART I, LINE 3 FAIR MARKET VALUE COMPARISON OF SIMILAR ORGANIZATIONS FORM 990, PART VI, SECTION A, LINE 2 JOHN LONDON AND CATHERINE LONDON ARE MARRIED. FORM 990, PART VI, SECTION B, LINE 11 THE COMPLETED FORM 990 IS SENT TO THE BOARD OF DIRECTORS PRIOR TO FILING FOR REVIEW AND APPROVAL. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION DISTRIBUTES A CONFLICT OF INTEREST POLICY TO EACH BOARD MEMBER ANNUAL AT THE BOARD MEETING. ALL STAFF AND BOARD MEMBERS ARE REQUIRED TO SIGN A CONFLICT OF INTEREST POLICY STATEMENT ON AN ANNUAL BASIS. ANY CONFLICTS THAT ARISE DURING THE COURSE OF THE YEAR ARE REQUIRED TO BE DISCLOSED AND RESOLVED BEFORE THE TRANSACTION IS COMPLETED. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION IS DETERMINED BY CONDUCTING A FAIR MARET VALUE COMPARISON OF OTHER ORGANIZATIONS BY THE BOARD CHAIR. FACTORS INCLUDE THE NUMBER OF HOURS WORKED AND THE BREADTH OF ROLES AND RESPONSIBILITIES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS AND FORM 990 ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART XII, LINE 2C THE BOARD OF DIRECTORS IS CHARGED WITH OVERSIGHT IN REGARDS TO REVIEW OF THE FINANCIALS AND SELECTION OF THE AUDITOR.